White House forcefully denies Trump got experimental obesity drug

MSN·Jun 23

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The White House has denied that Trump received an experimental obesity drug. There are reports of a 79-year-old patient gaining access to the drug, but it is unclear if this patient is Trump. The White House has pushed back against claims that Trump was given early access to the drug, also known as retatrutide.

Full coverage

White House Aggressively Denies Trump Received Exclusive Weight Loss Drug Access

Forbes·Jun 23

Why the Internet Thinks Trump Is on an Experimental Weight Loss Drug, and What the White House Has to Say About It

People.com·Jun 24

White House denies Trump is the ‘well-connected’ man who gained compassionate access to obesity drug in April

Yahoo·Jun 23

Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

STAT·Jun 23

Illinois Is Experiencing More Tornadoes — But Receiving Less Federal Disaster Aid

WTTW·Jun 25

White House denies Trump got early access to retatrutide

MSN·Jul 1

White House Pushes Back Against Claim That Trump Was Given Early Access to a Powerful Experimental Weight Loss Drug